Funder: National Institutes of Health
Due Dates: September 5, 2025 | January 5, 2026 | April 5, 2026 | September 5, 2026 | January 5, 2027 | April 5, 2027 | September 5, 2027
Funding Amounts: Up to $3,000,000 total costs per year (with prior approval); project period up to 5 years; typical awards are cooperative agreements (U44).
Summary: Supports U.S. small businesses to conduct exploratory clinical trials of investigational agents or devices in neurological disorders, leveraging the NeuroNEXT network.
Key Information: Requires a Community Engagement and Research Inclusion (CERI) Plan; only U.S. small businesses are eligible; pre-application consultation with NINDS is strongly encouraged.